478 related articles for article (PubMed ID: 26742086)
21. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
22. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2.
Demetriades C; Doumpas N; Teleman AA
Cell; 2014 Feb; 156(4):786-99. PubMed ID: 24529380
[TBL] [Abstract][Full Text] [Related]
23. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis.
Jiang L; Xu L; Mao J; Li J; Fang L; Zhou Y; Liu W; He W; Zhao AZ; Yang J; Dai C
J Am Soc Nephrol; 2013 Jun; 24(7):1114-26. PubMed ID: 23661807
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.
Li Y; Inoki K; Guan KL
Mol Cell Biol; 2004 Sep; 24(18):7965-75. PubMed ID: 15340059
[TBL] [Abstract][Full Text] [Related]
25. Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9.
Jung J; Genau HM; Behrends C
Mol Cell Biol; 2015 Jul; 35(14):2479-94. PubMed ID: 25963655
[TBL] [Abstract][Full Text] [Related]
26. Phospholipase D1 is an effector of Rheb in the mTOR pathway.
Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814
[TBL] [Abstract][Full Text] [Related]
27. Key mediators of intracellular amino acids signaling to mTORC1 activation.
Duan Y; Li F; Tan K; Liu H; Li Y; Liu Y; Kong X; Tang Y; Wu G; Yin Y
Amino Acids; 2015 May; 47(5):857-67. PubMed ID: 25701492
[TBL] [Abstract][Full Text] [Related]
28. Ras homolog enriched in brain (Rheb) enhances apoptotic signaling.
Karassek S; Berghaus C; Schwarten M; Goemans CG; Ohse N; Kock G; Jockers K; Neumann S; Gottfried S; Herrmann C; Heumann R; Stoll R
J Biol Chem; 2010 Oct; 285(44):33979-91. PubMed ID: 20685651
[TBL] [Abstract][Full Text] [Related]
29. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
Zech R; Kiontke S; Mueller U; Oeckinghaus A; Kümmel D
J Biol Chem; 2016 Sep; 291(38):20008-20. PubMed ID: 27493206
[TBL] [Abstract][Full Text] [Related]
30. CBAP regulates the function of Akt-associated TSC protein complexes to modulate mTORC1 signaling.
Liao WT; Chiang YJ; Yang-Yen HF; Hsu LC; Chang ZF; Yen JJY
J Biol Chem; 2023 Dec; 299(12):105455. PubMed ID: 37949232
[TBL] [Abstract][Full Text] [Related]
31. Amino acid regulation of TOR complex 1.
Avruch J; Long X; Ortiz-Vega S; Rapley J; Papageorgiou A; Dai N
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E592-602. PubMed ID: 18765678
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1.
Zheng M; Wang YH; Wu XN; Wu SQ; Lu BJ; Dong MQ; Zhang H; Sun P; Lin SC; Guan KL; Han J
Nat Cell Biol; 2011 Mar; 13(3):263-72. PubMed ID: 21336308
[TBL] [Abstract][Full Text] [Related]
33. Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.
Neuman NA; Henske EP
EMBO Mol Med; 2011 Apr; 3(4):189-200. PubMed ID: 21412983
[TBL] [Abstract][Full Text] [Related]
34. Rheb regulates nuclear mTORC1 activity independent of farnesylation.
Zhong Y; Zhou X; Guan KL; Zhang J
Cell Chem Biol; 2022 Jun; 29(6):1037-1045.e4. PubMed ID: 35294906
[TBL] [Abstract][Full Text] [Related]
35. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.
Foster KG; Acosta-Jaquez HA; Romeo Y; Ekim B; Soliman GA; Carriere A; Roux PP; Ballif BA; Fingar DC
J Biol Chem; 2010 Jan; 285(1):80-94. PubMed ID: 19864431
[TBL] [Abstract][Full Text] [Related]
36. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.
Oshiro N; Rapley J; Avruch J
J Biol Chem; 2014 Jan; 289(5):2658-74. PubMed ID: 24337580
[TBL] [Abstract][Full Text] [Related]
37. Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.
Lin Y; Henderson P; Pettersson S; Satsangi J; Hupp T; Stevens C
FEBS J; 2011 Jan; 278(2):354-70. PubMed ID: 21134130
[TBL] [Abstract][Full Text] [Related]
38. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.
Pryor WM; Biagioli M; Shahani N; Swarnkar S; Huang WC; Page DT; MacDonald ME; Subramaniam S
Sci Signal; 2014 Oct; 7(349):ra103. PubMed ID: 25351248
[TBL] [Abstract][Full Text] [Related]
39. Mammalian target of rapamycin complex I (mTORC1) activity in ras homologue enriched in brain (Rheb)-deficient mouse embryonic fibroblasts.
Groenewoud MJ; Goorden SM; Kassies J; Pellis-van Berkel W; Lamb RF; Elgersma Y; Zwartkruis FJ
PLoS One; 2013; 8(11):e81649. PubMed ID: 24303063
[TBL] [Abstract][Full Text] [Related]
40. The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.
Kang YJ; Lu MK; Guan KL
Cell Death Differ; 2011 Jan; 18(1):133-44. PubMed ID: 20616807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
